What amount sold does Remedium Bio Inc. report in Form D filings?

The latest linked filings report $5.9M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Remedium Bio Inc.'s most recent SEC filing?

Remedium Bio Inc.'s most recent Form D filing was on 2026-05-18.

How many investors does Remedium Bio Inc. have?

The most recent Form D filing lists 1 investor(s).

What type of securities does Remedium Bio Inc. offer?

Remedium Bio Inc.'s SEC Form D filings indicate equity offerings.

Remedium Bio Inc.

CIK: 0001892414·Biotechnology·NEEDHAM, MA·Corporation

Reported Sold

$5,934,955

Total Filings

Identified Offerings

Last Filed

May 18, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

May 18, 2026Form D — New notice

Reported sold: $1,500,000 · Target: $10,000,000

Rule 506(b)·1 investor

Aug 28, 2024Form D/A — Amendment

Reported sold: $4,434,955 · Target: $7,250,000

Rule 506(b)·26 investors

Changed: Reported amount sold, Offering target, Reported investors

Nov 9, 2021Form D — New notice

Reported sold: $1,370,000 · Target: $2,300,000

Rule 506(b)·6 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

33%

Latest reported sold across 2 identified offerings

$5,934,955

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Luppino Francesco

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
May 18, 2026	New	$10,000,000	$1,500,000	1
Aug 28, 2024	Amendment	$7,250,000	$4,434,955	26
Nov 9, 2021	New	$2,300,000	$1,370,000	6

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Auron Therapeutics, Inc.

Biotechnology

Offering target: $12,000,000

Filed Aug 13, 2026